100% Chitosan Haemostatic Dressing
- Sterile, ready to use
- Hypoallergenic, non-exothermic, non-pyrogenic
- Active on all sides
- Can be cut, folded, stuffed into deep wounds
- Protects wound from infection
Based on patented, clinically validated a.c.t (Axio clotting technology)
|Composition||Chitosan - 100%|
|Indication||Stops severe bleeding|
|Mechanism||Mucoadhesion due to change|
|Material||Positively charged, reacts actively|
|Type||Sponge, natural polymer|
|Flexibility||Very flexible, both sides active|
|Sterility||Sterilized using Gama irradiation|
|Shelf Life||3 Years|
|Removal||Irrigate with saline|
Military Trauma100% Chitosan Haemostatic DressingAxiostat® Military variant MIL88 is designed to be used in battlefield conditions and comes in camouflaged, rugged metal pouch packing for easy carrying
Axiostat® is currently used by Defense Forces, Paramilitary Forces & Army across India, Middle East and Europe
how to use axiostat
intended use / indication
Axiostat ® is a sterile, single use, non-absorbadle haemostatic dressing intended to be used for temporary control of bleeding wounds.
Axiostat ® stops moderate to severe bleeding due to cuts, abrasions, lacerations, venous or arterial bleeding.
Scalp & Limb Cuts,
Puncture or stab
Patients with blood
disorders or on blood
- The causes of death in conventional land warfare: implications for combat casualty care research. Bellamy RF. Military Medicine; 1984, 149(2):55-62.
- Review of new topical hemostatic dressings for combat casualty care. Bennett BL, Littlejohn L., Military Medicine; 2014, 179(5):497-514.
- Prehospital Application of Hemostatic Agents in Iraq and Afghanistan. Schauer SG. et al., Prehospital Emergency Care; 2018, 12:1-10.
- Assessing the Efficacy of Haemostatic Dressing Axiostat in Trauma Care at a Tertiary Care Hospital in India: A Comparison with Conventional Cotton Gauze. Patel K. et al., Indian Journal of Emergency Medicine; 2016, 2(2):93-99
- Studying Safety & Efficacy of Axiostat® Dressing in Acute Hemorrhage Due to Trauma-Comparative Study. Kabeer M. et al., 2012. ClinicalTrials.gov Identifier: NCT03035695.